Prognosis by stage

Haeseong Park gives survival estimates: ~70% cure for stage I, 40–50% five-year for locally advanced, poor for metastatic.

Play episode from 10:16

Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!